Clathrin-coated vesicles transport proteins and membranes between intracellular compartments. Adaptor molecules determine vesicle specificity; recently, a third type of adaptor protein, AP3, has been identified and implicated in the biogenesis of endosomal and lysosome-related organelles.
The secretory pathway of eukaryotic cells consists of an interconnected series of intracellular membranes. Transport between these compartments is mediated by coated vesicles, which all share a number of general features. For example, their formation involves the activation of coat proteins by GTP-binding proteins, the ordered assembly of the vesicle coat at the donor membrane, the selection of cargo molecules and the budding of the transport vesicle [1] . Until recently, there were four known types of coated vesicle: the COPI and COPII vesicles, which bud from the endoplasmic reticulum and trans-Golgi network, respectively, and two types of clathrin-coated vesicle. A further type of coated vesicle has recently been identified, defined by a specialised 'adaptor protein' known as AP3. AP3 has been implicated in vesicle biogenesis in a number of subcellular systems.
As the first transport vesicles to be identified, and still the best understood structurally, clathrin-coated vesicles have served as a powerful model system for studying coat formation in general. Clathrin-coated vesicles are required for receptor-mediated endocytosis at the plasma membrane, the export of lysosomal enzymes from the transGolgi network and early stages in the formation of dense-core granules in neuroendocrine cells. Clathrin forms an outer layer to the coat and probably plays a structural role in deforming the donor membrane. The vesicle specificity, however, is determined by the adaptor proteins, which lie underneath the clathrin layer and crosslink clathrin to the cytoplasmic tails of incorporated membrane receptors (Figure 1 ).
Each adaptor protein is composed of four, non-covalently associated subunits. There are two 100 kDa subunits called adaptins, together with a medium chain and a small chain. Clathrin-coated vesicles derived from either the plasma membrane or the trans-Golgi network differ in their cargo specificity and, as expected for molecules that define coat specificity, there are corresponding structural differences between adaptor proteins from the two locations. Briefly, the adaptor protein derived from the trans-Golgi network, AP1, is composed of γ and β1 adaptins, µ1 medium chain and σ1 small chain. The adaptor protein derived from the plasma membrane, AP2, is composed of α and β2 adaptins, µ2 medium chain and σ2 small chain (Figure 1a) . The adaptor forms a 'brick-like' structure in which the amino termini of the adaptins are bound to the small and medium chains. The carboxyl terminus of each adaptin protrudes symmetrically via a flexible proline-rich hinge and forms an 'ear-like' appendage to the main body of the protein [2] .
Even allowing for some redundancy in pathway components, it seems unlikely that four types of coated vesicle can account for all the known steps of membrane traffic in eukaryotic cells. Indeed, recently components of a new type of adaptor protein, designated AP3, have been identified, in part by screening the growing sequence databases for sequences likely to code for adaptor-related proteins. AP3 has the same general features as the other adaptor proteins: it is a heterotetramer, consisting of δ and β3 adaptins, µ3 medium chain and σ3 small chain. In mammals, the β and µ subunits both exist as separate nonbrain -β3A and µ3A -and brain-specific -β3B and µ3B -isoforms [3, 4] .
From the sequence similarity between the subunits of AP3 and those of the other known adaptor proteins, the overall shape of the complex is likely to be conserved, including the carboxy-terminal ears and flexible hinge on the adaptins ( Figure 1a ). The clathrin-binding site on the AP3 β subunit is also conserved, but there are contradictory reports as to whether AP3 actually binds clathrin in vivo [3, 5] . The assembly of AP3 onto membranes is enhanced by the nonhydrolysable GTP analogue GTPγS and can be inhibited by Brefeldin A, a drug which disrupts vesicle traffic at several locations within the cell. Brefeldin A is thought to act by interfering with the small GTPase component of the vesicle-target membrane fusion machinery known as ADPribosylation factor (ARF). These observations suggest that an ARF-like protein has a role in the activation of AP3, and are indicative of a mechanistic connection with the assembly of other types of coated vesicle [3] .
Sequences encoding an AP3 homologue have been found in the genome of the budding yeast Saccharomyces cerevisiae, so its function can be investigated by targeted gene inactivation. Deletion of the yeast AP3 gene is not lethal, but results in the mislocalisation of the vacuolar proteins alkaline phosphatase and Vamp3p (a t-SNARE). A major pathway from the yeast Golgi to the vacuolethe yeast equivalent of the lysosome -has previously been defined by the Vps class of mutants. Proteins known to be transported by the Vps pathway, such as carboxypeptidase Y, are not, however, affected by the inactivation of AP3 [6, 7] , so the new adaptor must define an alternative route to the vacuole.
A clue to the function of AP3 in other eukaryotes came with the observation that the AP3 subunit δ adaptin is the product of the garnet gene in Drosophila melanogaster [3, 8] . The garnet mutant fly was originally identified in 1916 by its pale eye colour, but the affected gene was not characterised in molecular detail until 1995. Photoreceptors in the insect compound eye are surrounded by pigment cells, which contain the pigment granules. In flies affected by mild mutant garnet alleles, the number of these granules is comparable to wild type but they contain much lower levels of pigment; more severe alleles cause a reduction in the number of pigment granules. As expected, Drosophila AP3 is expressed ubiquitously and, in some garnet mutants, the pigmentation of other organs is affected. The pigments themselves are small molecules, but the pigment granules must contain specialised proteins, such as enzymes, pigment transporters and so on; AP3 might be required for the correct transport of these macromolecules to the granules. Indeed, garnet interacts genetically with scarlet, which is believed to encode a pigment transporter [8] .
How does this observation square with data from yeast, which implicate AP3 in protein transport to the vacuole? The cell biology of Drosophila pigment granules has not been intensively studied. Pigment granules in vertebrate melanocytes, known as melanosomes, have been studied in more detail. There is good evidence that melanosomes have features in common with lysosomes, with which they probably share some aspects of their biogenesis. In patients with Chediak Higashi disease and in beige mutant mice, for example, lysosomes and melanosomes are both defective and grossly enlarged [9] . Recent work on two other mouse mutants has now directly confirmed the importance of the AP3 coat in the biosynthesis of these lysosome-like organelles.
The mocha mutant mouse exhibits pleiotropic defects, including abnormal hair and eye colour, prolonged bleeding and reduced secretion of lysosomal enzymes in urine. By genetic mapping, the mutation has been identified as a null allele of the gene for δ adaptin -mocha is thus the mouse equivalent of garnet [10] . Furthermore, cells from mocha mice show little trace of any of the other AP3 subunits suggesting that the δ subunit is critical for the stability of the whole complex. The abnormal pigmentation of mocha mice probably reflects reduced transport of proteins to melanosomes, similar to the pigment granule defect of garnet mutant flies. The abnormal blood clotting can similarly be explained by disrupted transport to another lysosome-like organelle, the platelet dense-core granule.
A second mutant, the pearl mouse, also shows unusual hair colour, and has abnormal lysosomes, melanosomes and platelet granules. This too has been characterised in more detail and shown to be accompanied by reduced expression of the non-brain β3A subunit of AP3 [11] . Quite apart from the immediate interest in uncovering a new coat system, these mutant mice may shed light on a group of serious R610 Current Biology, Vol 8 No 17 Figure 1 (a) Generic structure of the adaptor complex, as inferred from electron microscopy, limited proteolytic digestion and structural predictions [1, 2] . All adaptors consist of a β-class adaptin associated with either an α, γ or δ adaptin, together with a µ chain and a σ chain. In the case of AP3, there are brain-specific isoforms of β3 and µ3. The carboxyl termini of the adaptins form a separate domain connected to the main body by a flexible and relatively open hinge. (b) The adaptors define the specificity of the coated pit by binding signal motifs on the cytoplasmic face of selected membrane proteins. In the case of AP1 and AP2, and possibly AP3 [3, 5] , clathrin binds to and crosslinks the assembled adaptor proteins, trapping them and their associated cargo in the growing coated pit. This invaginates further and detaches to form the coated vesicle. human inherited conditions. Patients with Hermansky Pudlak Syndrome have many of the characteristics of the mocha and pearl mice, including pale pigmentation, bleeding disorders and lysosome abnormalities [12] . Hermansky Pudlak Syndrome is genetically heterogeneous, but in the light of the recent work on mocha and pearl mice, it should be interesting to look closely at the human genes encoding AP3 components as candidate targets of mutations causing this condition.
Adaptor proteins achieve their selectivity by binding to a short signal sequence on the cytoplasmic tail of transmembrane receptors. A variety of such signals has been identified in diverse membrane proteins. The best understood is a family of sequences based on the consensus sequence Yxx∅, where Y is a characteristic tyrosine, ∅ is a bulky hydrophobic amino acid and x is any amino acid. A signal sequence of this type binds to the adaptor µ chain, but individual µ chains differ in their affinity for specific sequences within this broad class. A given membrane protein may associate preferentially, but not exclusively, with a particular adaptor. AP3 with either µ3A and µ3B binds tyrosine-containing signals with a distinct specificity that nevertheless partially overlaps those of AP1 and AP2 [13] . This could account for the fact the melanosomes of mocha and pearl mice are not completely empty -the mice are not albino. It is likely that melanosome proteins can be correctly targeted with limited efficiency by alternative AP1-or AP2-dependent pathways, and it is interesting to note that AP3-deficient yeast strains succeed in diverting some alkaline phosphatase to the Vps pathway [7] .
A second class of sorting signal is built around a dileucine motif. This signal is recognised by a separate site on adaptor proteins, and again there are variations in the affinity of different adaptors for individual dileucine sequences. The lysosomal protein LIMP-II and the melanosome enzyme tyrosinase contain a dileucine sequence next to a cluster of two to three acidic residues; peptides containing this motif bind strongly to AP3, but only weakly to AP1 or AP2 [14] . This observation is nicely consistent with the view that AP3 has a specialised role in the biogenesis of lysosomes and melanosomes.
The mocha mice are also afflicted with a variety of neurological disorders, including seizures and hyperactivity. This suggests that AP3 has additional roles in the brain. The pearl mice, however, are spared neurological symptoms. This is almost certainly because brain-type AP3 uses the brain-specific adaptin β3B, which is unaffected by the pearl mutation. A surprising characteristic of the brains from mocha mice is the specific loss of zinc, as detected by histochemical staining [10] . Cortical and hypothalamic neurons contain specialised synaptic-like vesicles that store zinc ions, which are released together with the transmitter glutamate during excitation. Why loss of AP3 should lead to such a specific deficiency is not clear, but zinc transporters are known to be present in the central nervous system [15] and it will be interesting to see whether AP3 is required for the correct targeting of these proteins to synaptic vesicles.
This observation is consistent with other recent results pointing to a role for AP3 in synaptic vesicle biogenesis. In cultured neuroendocrine PC12 cells, the intrinsic membrane proteins of synaptic vesicles are first exported to the plasma membrane, then internalised by AP2-containing clathrin-coated pits and delivered to endosomes, from where they are targeted to synaptic vesicles. In a cell-free assay, budding from endosomal membranes was shown to depend on AP3 as the main coat protein [16] . Although synaptic vesicles may not seem to be closely related to melanosomes and lysosomes, all three can be labelled from the plasma membrane via endosomal intermediates. The intracellular distribution of AP3 does suggest at least some endosomal localization [4] , so an attractive unifying idea is that AP3 may mediate a number of separate sorting decisions at this organelle.
There are almost certainly other types of vesicle coat remaining to be discovered, and the expanding database of expressed genomic sequences should be a rich mine in this quest. Indeed, several more adaptin-like sequences, probably constituting a fourth type of coat, have been identified by screening this database for adaptor protein homologues. Unfortunately, we cannot assume this approach will work for all the missing coats. Although some COPI components are homologous to individual adaptins, the sequence identity is weak and there is no discernible sequence similarity between adaptors and COPII proteins at all [1] . It seems likely therefore that additional search strategies will have to be adopted before our inventory of eukaryotic coated vesicles is complete.
